Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy.

Keywords

Medicine, Discontinuation, Hormone replacement therapy (female-to-male), Breast density, Confidence interval

References

• Mammographic densities and risk of breast cancerJosé Suay Rincón — 1991
• Are long-term hormone replacement therapy users different from short-term and never users?一博 酒井, 和孝 小木, 一 斎藤 — 1999
• Pharmacokinetic data on estradiol in light of the estring concept. Estradiol and estring pharmacokinetics.Johan Gabrielsson, Ingrid Wallenbeck, L. Birgerson — 1996
• Mammographic parenchymal patterns and breast cancer risk.Audrey F. Saftlas, Moysés Szklo — 1987
• Mammographic parenchymal patterns: a marker of breast cancer risk.Amit M. Oza, Norman F. Boyd — 1993
• Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.Mary B. Laya, E. B. Larson, Stephen H. Taplin — 1996
• Hormonal replacement therapy: mammographic manifestations.J E Berkowitz, Olga M. B. Gatewood, L E Goldblum — 1990
• The effect of hormone replacement therapy on the sensitivity of screening mammograms.Janet Litherland, Sheila Stallard, D. Hole — 1999
• Hormone replacement therapy and accuracy of mammographic screening.Anne Kavanagh, Heather Mitchell, Graham G. Giles — 2000
• Mammographic breast density during hormone replacement therapy: differences according to treatment.Eva Lundström, Brigitte Wilczek, Zoltan von Palffy — 1999
• The mammographic parenchymal patterns of women on hormonal replacement therapy.Z Kaufman, W.I.H. Garstin, Robert L. Hayes — 1991
• Clinically useful measures of effect in binary analyses of randomized trials.John C. Sinclair, Michael B. Bracken — 1994
• The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patternsKirby I. Bland, Jerry B. Buchanan, Barbara F. Weisberg — 1980
• Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.Paul C. Stomper, Bradley J. Van Voorhis, Veronica A. Ravnikar — 1990
• Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.Margaret T. Mandelson — 2000
• Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programmeB. Séradour, Jacques Estève, Patrice Heid — 1999
• Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population.Stephen H. Taplin, Margaret T. Mandelson, Carolyn Anderman — 1997
• Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.Mary B. Laya, John C. Gallagher, J S Schreiman — 1995
• The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification.Ellen Warner, G.R. Lockwood, David Tritchler — 1992

Cited by

• Mammographic breast density as a biomarker of effects of isoflavones on the female breastMatthew T. Ferenc, Raùl Radovitzky, Cameron R. Bass — 2001
• Progestins and breast cancer.Joseph Margolis, Clorinda G. Margolis — 2003
• Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidenceChristian Topalov — 2008
• Progestin may modify the effect of low-dose hormone therapy on mammographic breast densityConstantinos Panoulis, Ιrene Lambrinoudaki, A. Vourtsi — 2009
• Evaluating hormone therapy-associated increases in breast density comparison between reported and simultaneous assignment of BI-RADS categories, visual assessment, and quantitative analysis.Jennifer A. Harvey, Viktor E. Bovbjerg, Mark E. Smolkin — 2005
• Mammographic Breast Density and Breast Cancer Risk: Implications of the Breast Density Legislation for Health Care Practitioners隆 吉松, 憲司 小野, 将一 菅谷 — 2016
• Modeling Prolactin Actions in Breast Cancer in vivo: Insights from the NRL-PRL MouseKathleen A. O’Leary, Michael P. Shea, Linda A. Schuler — 2015
• COMMON VARIATION IN THE FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) GENE, HORMONE THERAPY USE, AND MAMMOGRAPHIC BREAST DENSITYYan Du — 2010
• Postmenopausal Hormone Replacement Therapy: Effects on Normal Mammary Gland in Humans and in a Mouse Postmenopausal ModelSandra Z. Haslam, Janet R. Osuch, Ahmed Raafat — 2004
• The Effects of Anthropometry and Angiogenesis on Breast Cancer EtiologyKatherine W. Reeves — 2008
• Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk?Susen Becker, Rudolf Kaaks — 2009
• Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view.Leon Speroff — 2004
• Terapia ormonale sostitutiva in menopausaGiuseppina Padova, Daniela Minnella, Valeria Velardita — 2002
• Development and Evaluation of a Method for Measuring Breast DensityJennifer Diffey — 2012
• Clinical and epidemiological issues and applications of mammographic densityValentina Assi — 2014
• Metabolic Mapping of Breast Cancer with Multiphoton Spectral and Lifetime ImagingLong Yan — 2007
• Hormontherapie und Brustvon Schoultz B — 2004
• Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over timeGrace Chew, D. Huang, Chengfu Huo — 2013
• Mammographic density and breast cancer phenotypesLouise Eriksson — 2012
• Association between changes in hormone replacement therapy and breast density.Carolyn M. Rutter — 2001

Related papers

• Mammographic density. Measurement of mammographic densityMartin J. Yaffe — 2008
• Accuracy of assigned BI-RADS breast density category definitions.Brandi T. Nicholson, Alexander P. LoRusso, Mark E. Smolkin — 2006
• Description of breast density based on a homogeneity representationIgnacio Valencia‐Hernández, Hayde Peregrina‐Barreto, Carlos A. Reyes-García — 2019
• The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonographyIrma Saarenmaa, Tiina Salminen, U. Geiger — 2001
• The effects of raloxifene on mammographic breast density: a review of clinical trialsLeny Pearman, Risa Kagan, Jody Arsenault — 2009
• Breast density in Saudi Arabia: intra and inter reader variability in screening mammograms assessed visually using BI-RADS and visual analogue scalesAreej S. Aloufi, Abdulrahman AlNaeem, Abeer Almousa — 2020
• Mammographic density in women on postmenopausal hormone replacement therapy.Winnie Leung, Franklin Goldberg, Benny Zee — 1997